Flores-Maya MA, Vázquez-Nieves JR, Arroyo-Zavala OJ, Laredo-Gómez J

Language: Spanish
References: 13
Page: 40-47
PDF size: 384.77 Kb.

ABSTRACT

The new severe acute respiratory syndrome due to coronavirus type 2 (SARS-CoV-2), which causes COVID-19 disease, was detected for the first time in December 2019. Where it has been seen that there is a prothrombotic state with involvement of the Central Nervous, with involvement of large vessels such as the middle cerebral artery, is due to mechanisms induced by the infection itself, hypercoagulable state and endothelial damage. Neurological manifestations in COVID-19 are found in 36% of patients.
Case description: This is a 36-year-old male patient with fever, cough and general malaise. A COVID test was performed, which came out positive. His condition was getting worse adding photophobia, right hemiparesis and deviation of the corner of the mouth to the left, which is why he went to the doctor, arriving 8 hours after the onset of the clinical picture, where a simple skull tomography was performed, showing extensive infarction of the left middle cerebral artery with malignant cerebral edema. He was transferred to emergency surgical management where a left decompressive craniectomy was performed. After this, mechanical respiratory assistance with intubation and anti-cerebral edema measures were maintained, achieving ventilatory progression; however, a tracheostomy and gastrostomy were performed due to poor predictors of extubation. He was kept under post-surgical observation, leaving him with 3/5 right hemiparesis, without any other deficit, therefore, he was discharged home.
Discussion: The case presented was managed with decompressive craniectomy, resulting in an improvement in survival, as reported in the literature where it is recommended that such management should be performed early.
Conclusions: This report reveals that patients with COVID-19 present in young men in the fourth and fifth decade of life, without comorbidities, that recieved early treatment with decompressive hemicraniectomy, improved their life prognosis, consistent with the cases presented in the literature.

REFERENCES

1. Tunç A, Ünlübaş Y, Alemdar M, Akyüz E. Coexistenceof COVID-19 and acute ischemic stroke report of fourcases. Journal of Clinical Neuroscience. 2020:77:227-229.https://doi.org/10.1016/j.jocn.2020.05.018

2. John S, Kesav P, Mifsud V, Piechowski-Jozwiak B, Dibu J,Bayrlee A, Elkambergy H, Roser F, Elhammady M, ZahraK, Hussain S. Characteristics of Large-Vessel OcclusionAssociated with COVID-19 and Ischemic Stroke. AmericanJournal of Neuroradiology. 2020;41(12):2263-2268.https://doi.org/10.3174/ajnr.a6799

3. Kihira S, Schefflein J, Mahmoudi K, Rigney B, Delman BN,Mocco J, Doshi, A, Belani P. Association of CoronavirusDisease (COVID-19) With Large Vessel Occlusion Strokes:A Case-Control Study. American Journal of Roentgenology.2021;216(1):150-156. https://doi.org/10.2214/ajr.20.23847

4. Roy D, Hollingworth M, Kumaria A. A case of malignantcerebral infarction associated with COVID-19 infection.British Journal of Neurosurgery. 2020;35(2):191-194.https://doi.org/10.1080/02688697.2020.1779180

5. Rothstein A, Oldridge O, Schwennesen H, Do D, CucchiaraBL. Acute Cerebrovascular Events in HospitalizedCOVID-19 Patients. Stroke. 2020;51(9). https://doi.org/10.1161/strokeaha.120.030995

6. Zhang S, Zhang J, Wang C, Chen X, Zhao X, Jing H, LiuH, Li Z, Wang L, Shi J. COVID19 and ischemic stroke:Mechanisms of hypercoagulability (Review). InternationalJournal of Molecular Medicine. 2021:47(3). https://doi.org/10.3892/ijmm.2021.4854

7. Chan KIP, Salonga AEM, Khu KJO. Decompressive hemicraniectomyfor acute ischemic stroke associated with coronavirusdisease 2019 infection: Case report and systematicreview. Surgical Neurology International. 2021;12:116.https://doi.org/10.25259/sni_64_2021

8. Das S, Mitchell P, Ross N, Whitfield PC. Decompressivehemicraniectomy in the treatment of malignant middlecerebral artery infarction: A meta-analysis. World Neurosurg.2019;123:8-16.

9. Rodrigues TP, Rodrigues MAS, Bocca LF, Chaddad-NetoFE, Cavalheiro S, Junior EA, Silva GS, Suriano IC, CentenoRS. Decompressive craniectomy index: Does the sizeof decompressive craniectomy matter in malignant middlecerebral artery infarction? Surgical Neurology International.2022;13:580. https://doi.org/10.25259/SNI_895_2022

10. Wagner S, Schnippering H, Aschoff A, Koziol JA, Schwab S,Steiner T. Suboptimum hemicraniectomy as a cause of additionalcerebral lesions in patients with malignant infarctionof the middle cerebral artery. J Neurosurg. 2001;94:693-6.

11. Schur S, Martel P, Marcoux J. Optimal bone flap size fordecompressive craniectomy for refractory increased intracranialpressure in traumatic brain injury: Taking the patient’shead size into account. World Neurosurg. 2020;137:430-6.

12. Holtkamp M, Buchheim K, Unterberg A, Hoffmann O,Schielke E, Weber JR. Hemicraniectomy in elderly patientswith space occupying media infarction: improved survivalbut poor functional outcome. J Neurol Neurosurg Psychiatry.2001;70:226-8.

13. Vibbert M, Mayer SA. Early decompressive hemicraniectomyfollowing malignant ischemic stroke: The crucialrole of timing. Curr Neurol Neurosci Rep. 2010;10:1-3.